These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 22890512

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.
    Barlas UK, Kıhtır HS, Goknar N, Ersoy M, Akcay N, Sevketoglu E.
    Pediatr Nephrol; 2018 Jun; 33(6):1093-1096. PubMed ID: 29558000
    [Abstract] [Full Text] [Related]

  • 23. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
    Sengul Samanci N, Ayer M, Ergen A, Ozturk S.
    Transfus Apher Sci; 2015 Jun; 52(3):314-6. PubMed ID: 25634788
    [Abstract] [Full Text] [Related]

  • 24. Eculizumab in atypical haemolytic uraemic syndrome with severe cardiac and neurological involvement.
    Hu H, Nagra A, Haq MR, Gilbert RD.
    Pediatr Nephrol; 2014 Jun; 29(6):1103-6. PubMed ID: 24317637
    [Abstract] [Full Text] [Related]

  • 25. Eculizumab therapy on a patient with co-existent lupus nephritis and C3 mutation-related atypical haemolytic uremic syndrome: a case report.
    Kim MJ, Lee H, Kim YH, Jin SY, Kim HJ, Oh D, Jeon JS.
    BMC Nephrol; 2021 Mar 10; 22(1):86. PubMed ID: 33691638
    [Abstract] [Full Text] [Related]

  • 26. A Rare Case of Lupus Nephritis Presenting as Thrombotic Microangiopathy with Diffuse Pseudotubulization Possibly Caused by Atypical Hemolytic Uremic Syndrome.
    Ono M, Ohashi N, Namikawa A, Katahashi N, Ishigaki S, Tsuji N, Isobe S, Iwakura T, Sakao Y, Tsuji T, Kato A, Fujigaki Y, Shimizu A, Yasuda H.
    Intern Med; 2018 Jun 01; 57(11):1617-1623. PubMed ID: 29434134
    [Abstract] [Full Text] [Related]

  • 27. [Atypical hemolytic uremic syndrome in an elderly patient successfully treated with eculizumab].
    Fukasawa C, Ooishi S, Kumagai T, Koshiisi M, Sueki Y, Nakajima K, Mitsumori T, Yoshida Y, Kato H, Nangaku M, Miyata T, Kirito K.
    Rinsho Ketsueki; 2018 Jun 01; 59(2):182-186. PubMed ID: 29515071
    [Abstract] [Full Text] [Related]

  • 28. Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab.
    Besbas N, Gulhan B, Karpman D, Topaloglu R, Duzova A, Korkmaz E, Ozaltin F.
    Pediatr Nephrol; 2013 Jan 01; 28(1):155-8. PubMed ID: 22956028
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Efficacy of Eculizumab Therapy for Atypical Hemolytic Uremic Syndrome Recurrence and Antibody-Mediated Rejection Progress After Renal Transplantation With Preformed Donor-Specific Antibodies: Case Report.
    Yamamoto T, Watarai Y, Futamura K, Okada M, Tsujita M, Hiramitsu T, Goto N, Narumi S, Takeda A, Kobayashi T.
    Transplant Proc; 2017 Jan 01; 49(1):159-162. PubMed ID: 28104125
    [Abstract] [Full Text] [Related]

  • 33. Ten-year outcome of Eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome- a single center experience.
    Kant S, Bhalla A, Alasfar S, Alachkar N.
    BMC Nephrol; 2020 May 20; 21(1):189. PubMed ID: 32434487
    [Abstract] [Full Text] [Related]

  • 34. Eculizumab Modifies Outcomes in Adults with Atypical Hemolytic Uremic Syndrome with Acute Kidney Injury.
    Cao M, Leite BN, Ferreiro T, Calvo M, Fernández C, Alonso Á, Rodriguez A, Salvador P, Seijo R, Pita S, Arjona E, Rodríguez de Córdoba S, Valdés Cañedo F.
    Am J Nephrol; 2018 May 20; 48(3):225-233. PubMed ID: 30205388
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Complement inhibitor eculizumab in atypical hemolytic uremic syndrome.
    Mache CJ, Acham-Roschitz B, Frémeaux-Bacchi V, Kirschfink M, Zipfel PF, Roedl S, Vester U, Ring E.
    Clin J Am Soc Nephrol; 2009 Aug 20; 4(8):1312-6. PubMed ID: 19556379
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of eculizumab in adult patients with atypical hemolytic uremic syndrome: A single center experience from Turkey.
    Gediz F, Payzin BK, Ecemis S, Güler N, Yilmaz AF, Topcugil F, Berdeli A.
    Transfus Apher Sci; 2016 Dec 20; 55(3):357-362. PubMed ID: 27742267
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.